The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease.


Journal

Current opinion in pharmacology
ISSN: 1471-4973
Titre abrégé: Curr Opin Pharmacol
Pays: England
ID NLM: 100966133

Informations de publication

Date de publication:
12 2020
Historique:
received: 20 05 2020
revised: 19 07 2020
accepted: 20 08 2020
pubmed: 10 10 2020
medline: 14 10 2021
entrez: 9 10 2020
Statut: ppublish

Résumé

Faecal microbiota transplantation (FMT) has emerged as a potent form of therapeutic microbial manipulation. There is much interest in exploring its potential in conditions such as inflammatory bowel disease (IBD) where disturbances in the gastrointestinal microbiota play a crucial role in disease pathogenesis. There are 4 randomized controlled trials of FMT as induction therapy in ulcerative colitis, with meta-analyses suggesting significant benefit over placebo. Allied microbial studies have identified potential microbial and metabolic predictors of therapeutic efficacy and highlighted the importance of optimizing future donor and patient selection. Recent literature has evaluated the use of complementary microbial manipulation through pre-antibiotics to improve treatment efficacy. Studies have also assessed the durability of FMT response and its use in maintenance therapy of UC. While data on FMT are more limited in Crohn's disease and pouchitis, cohort and pilot randomized controlled data a now also emerging in these areas.

Identifiants

pubmed: 33035780
pii: S1471-4892(20)30060-6
doi: 10.1016/j.coph.2020.08.009
pmc: PMC7538387
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-16

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Dig Dis Sci. 2020 Apr;65(4):1107-1110
pubmed: 31529413
Inflamm Bowel Dis. 2016 Sep;22(9):2182-90
pubmed: 27542133
JAMA. 2019 Jan 15;321(2):156-164
pubmed: 30644982
Lancet Gastroenterol Hepatol. 2020 May;5(5):430-432
pubmed: 32192627
Gastroenterology. 2015 Jul;149(1):110-118.e4
pubmed: 25836986
JAMA. 2017 Nov 28;318(20):1985-1993
pubmed: 29183074
JAMA. 2014 Nov 5;312(17):1772-8
pubmed: 25322359
PLoS One. 2017 Jan 26;12(1):e0170922
pubmed: 28125667
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435
pubmed: 32199469
Gut. 2017 Apr;66(4):569-580
pubmed: 28087657
Inflamm Bowel Dis. 2017 Jan;23(1):116-125
pubmed: 27893543
Inflamm Intest Dis. 2019 May;4(1):1-6
pubmed: 31172007
J Crohns Colitis. 2016 Apr;10(4):387-94
pubmed: 26519463
Gastroenterology. 2019 Feb;156(3):748-764
pubmed: 30576644
Gut. 2018 Nov;67(11):1920-1941
pubmed: 30154172
J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):343-347
pubmed: 30320666
Microbiome. 2020 Feb 3;8(1):12
pubmed: 32014035
JAMA. 2016 Jan 12;315(2):142-9
pubmed: 26757463
Curr Gastroenterol Rep. 2013 Aug;15(8):337
pubmed: 23852569
Dig Dis Sci. 2020 Apr;65(4):1099-1106
pubmed: 31302808
Gastroenterology. 2014 May;146(6):1573-1582
pubmed: 24412527
Appl Microbiol Biotechnol. 2019 Jan;103(1):349-360
pubmed: 30357440
J Gastroenterol Hepatol. 2015 Jan;30(1):51-8
pubmed: 25168749
Gut Pathog. 2020 Apr 9;12:16
pubmed: 32308741
J Crohns Colitis. 2018 May 25;12(6):710-717
pubmed: 29528385
Am J Gastroenterol. 2017 Jun;112(6):940-947
pubmed: 28195180
Aliment Pharmacol Ther. 2017 Sep;46(5):479-493
pubmed: 28707337
Am J Gastroenterol. 2016 Aug;111(8):1141-6
pubmed: 27215924
Gastroenterology. 2019 Apr;156(5):1440-1454.e2
pubmed: 30529583
Scand J Gastroenterol. 2005 Nov;40(11):1334-42
pubmed: 16334443
Gut. 2020 May;69(5):801-810
pubmed: 32047093
J Crohns Colitis. 2019 Sep 27;13(10):1311-1317
pubmed: 30873549
Gut Microbes. 2017 Nov 2;8(6):574-588
pubmed: 28723262
Gut Microbes. 2017 May 4;8(3):303-309
pubmed: 28102756
J Gastroenterol Hepatol. 2020 Mar;35(3):418-424
pubmed: 31408913
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1433-8
pubmed: 26905904
J Gastroenterol Hepatol. 2020 Sep;35(9):1515-1523
pubmed: 32017248
J Crohns Colitis. 2017 Oct 1;11(10):1180-1199
pubmed: 28486648
Am J Gastroenterol. 2016 Mar;111(3):441-3
pubmed: 27018122
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
Gut. 2018 Aug;67(8):1558-1559
pubmed: 29066574
Gastroenterology. 2021 Jan;160(1):115-127.e30
pubmed: 32763240
ISME J. 2017 Aug;11(8):1877-1889
pubmed: 28398347
N Engl J Med. 2019 Nov 21;381(21):2043-2050
pubmed: 31665575
Cell Host Microbe. 2020 May 13;27(5):823-829.e3
pubmed: 32298656
Gastroenterology. 2015 Jul;149(1):102-109.e6
pubmed: 25857665
Mucosal Immunol. 2017 Mar;10(2):565-566
pubmed: 28000680
J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):597-601
pubmed: 23542823
Inflamm Bowel Dis. 2016 Oct;22(10):2402-9
pubmed: 27580384
Lancet. 2017 Mar 25;389(10075):1218-1228
pubmed: 28214091
Inflamm Bowel Dis. 2013 Jun;19(7):1506-13
pubmed: 23624888

Auteurs

Craig Haifer (C)

Concord Clinical School, The University of Sydney, New South Wales, Australia; Department of Gastroenterology, Concord Repatriation General Hospital, New South Wales, Australia.

Rupert W Leong (RW)

Concord Clinical School, The University of Sydney, New South Wales, Australia; Department of Gastroenterology, Concord Repatriation General Hospital, New South Wales, Australia; Department of Gastroenterology, Macquarie University & Macquarie University Hospital, New South Wales, Australia.

Sudarshan Paramsothy (S)

Concord Clinical School, The University of Sydney, New South Wales, Australia; Department of Gastroenterology, Concord Repatriation General Hospital, New South Wales, Australia; Department of Gastroenterology, Macquarie University & Macquarie University Hospital, New South Wales, Australia. Electronic address: sudarshan.paramsothy@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH